Skip to main content
. Author manuscript; available in PMC: 2010 Nov 9.
Published in final edited form as: Am J Transplant. 2005 Jun;5(6):1430–1436. doi: 10.1111/j.1600-6143.2005.00874.x

Table 2.

Patients presenting confirmed GVHD

Pt# Type ITx Sex Donor
sex
Donor
BM
Site of
GVHD
Presentation
(Post-ITx days)
Grade
GVHD*
Flow cytometry
at symptoms**
(Post-ITx days)
Flow cytometry
follow-up**
(Post-ITx days)
1 L/SB/P M M N Skin 24 I 16.1 (21) 2.5 (62)
2 L/SB/P M M N Skin 23 I 14.1 (20) 6.7 (64)
3 SB F M N Skin 60 II 0.9 (27) 3.5(47)/15(61)
4 SB M F N Skin 30 I 6.8 (52) ND
*

Histologic classification of skin changes in GVHD (Grade I–IV).

**

Percentage of donor derived cells in peripheral blood of recipient in one or two separate measurements.

ND = not done.